Posts by Sarah N. Bernstein, MD
Acceptability of Virtual Prenatal Care: Thinking Beyond the Pandemic
Sarah N. Bernstein, MD, Mackenzie W. Sullivan, MD, and colleagues found that 95% of patients who received virtual prenatal care said virtual visits should continue to be offered, and 65% said they would prefer to incorporate virtual visits in their future prenatal care.
Fentanyl in Labor Epidural Can Affect Results of Maternal and Neonatal Toxicology Tests
Molly R. Siegel, MD, and Sarah N. Bernstein, MD, demonstrated when fentanyl is given as part of the labor epidural, up to 91% of maternal toxicology tests and up to 80% of neonatal tests are positive for the drug. Care should be taken in interpreting toxicology results to avoid false assumptions of non-prescribed use.
Managing the Cardiovascular Complications of Substance Use Disorders During Pregnancy
The normal physiologic changes in pregnant women can be rapidly accelerated or blunted in the setting of active substance use, potentially leading to catastrophic cardiac effects in the mother.
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
A multidisciplinary, 1000-day clinical model offers a new approach to prenatal and postnatal care for mothers with opioid use disorder and their children.
Sarah N. Bernstein, MD, is a maternal-fetal medicine specialist at Massachusetts General Hospital.